Randomized trials in oncology stopped early for benefit

Journal of Clinical Oncology

Volumn 26, Issue 1, 2008, Pages 18-19

  Wilcox, Ryan A ^a   Djulbegovic, Benjamin ^a   Guyatt, Gordon H ^a   Montori, Victor M ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER PATIENT; CANCER SURVIVAL; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG WITHDRAWAL; HUMAN; MEDICAL LITERATURE; MULTIPLE CYCLE TREATMENT; MYELOID LEUKEMIA; NOTE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS DATA MONITORING COMMITTEES; HUMANS; LEUKEMIA, MYELOID, ACUTE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 37849036019     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.13.6259     Document Type: Note

References (8)

1. Montori VM, Devereaux PJ, Adhikari NK, et al: Randomized trials stopped early for benefit: A systematic review. JAMA 294:2203-2209, 2005
2. Wheatley K, Clayton D: Be skeptical about unexpected large apparent treatment effects: The case of an MRC AML12 randomization. Control Clin Trials 24:66-70, 2003
3. Segota E, Soares HP, Djulbegovic B, et al: Randomized clinical trials in oncology stopped early for benefit (RCTSEB). J Clin Oncol 24, 2006 (abstr 6039)
4. Djulbegovic B, Hozo I: When should potentially false research findings be considered acceptable? PLoS Med 4:e26, 2007
5. Mueller PS, Montori VM, Bassler D, et al: The ethics of stopping clinical trials early. Ann Intern Med (in press), 2007
6. Poldermans D, Boersma E, Bax JJ, et al: The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery: Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 341:1789-1794, 1999
7. Yang H, Raymer K, Butler R, et al: The effects of perioperative beta-blockade: Results of the Metoprolol after Vasc Surg (MaVS) study, a randomized controlled trial. Am Heart J 152:983-990, 2006
8. McCullough PA: Failure of beta-blockers in the reduction of perioperative events: Where did we go wrong? Am Heart J 152:815-818, 2006